News

Seegene Notification about the detectability of Omicron variant, B.1.1.529

We received the notification from Seegene, in which they confirmed the detectability of Allplex™ assays with respect to the Omicron variant, B.1.1.529 of SARS-CoV-2, which has emerged in South Africa.

Read more

Successful evaluation of the BÜHLMANN fPELA® turbo test at Synlab in Lucerne

Interview with Dr. Cyril A. Fuhrer about the successful evaluation of the BÜHLMANN fPELA® turbo test at Synlab Suisse SA in Lucerne.

Read more

Successful evaluation of the BÜHLMANN fPELA® turbo test at Dianalabs in Geneva

Interview with Dr. Marc-Antoine Bagnoud about the successful evaluation of the BÜHLMANN fPELA® turbo test at Dianalabs in Geneva.

Read more

Seegene shows for the first time the innovative MOBILE STATION at MedLab in Dubai

Seegene MOBILE STATION is an innovative solution that can help bring our lives back to normal.

Read more